2024-10-23 04:52:20
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy
Corporate/ 2023-07-24
Alterity Therapeutics Launches ATH434 Ph...

Multiple System Atrophy is a rare,rapidly progressive,neurodegenerative disease that causes profound disability

IASO Bio and Innovent Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Health/ 2023-07-22
IASO Bio and Innovent Jointly Announce t...

SHANGHAI,NANJING,China,and SAN JOSE,Calif.,June 2,2022--IASO Biotherapeutics ("IASO Bio"),a clinical-stage biopharmaceutical compa...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release